Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
Orion Oyj Stock

Orion Oyj Stock ORNBV.HE

ORNBV.HE
FI0009014377
A0J3QM

Price

0
Today +/-
-0
Today %
-0 %

Orion Oyj stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Orion Oyj stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Orion Oyj stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Orion Oyj stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Orion Oyj's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Orion Oyj Stock Price History

DateOrion Oyj Price
8/4/20250 undefined
8/1/202570.30 undefined
7/31/202570.30 undefined
7/30/202570.80 undefined
7/29/202570.50 undefined
7/28/202569.95 undefined
7/25/202570.55 undefined
7/24/202570.95 undefined
7/23/202570.35 undefined
7/22/202569.70 undefined
7/21/202569.30 undefined
7/18/202569.45 undefined
7/17/202566.05 undefined
7/16/202566.25 undefined
7/15/202565.95 undefined
7/14/202566.25 undefined
7/11/202566.85 undefined
7/10/202566.85 undefined
7/9/202565.55 undefined
7/8/202565.64 undefined
7/7/202563.40 undefined

Orion Oyj Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Orion Oyj, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Orion Oyj from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Orion Oyj’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Orion Oyj. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Orion Oyj’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Orion Oyj’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Orion Oyj’s growth potential.

Orion Oyj Revenue, EBIT and net profit per share

DateOrion Oyj RevenueOrion Oyj EBITOrion Oyj Net Income
2030e2.6 B undefined0 undefined649.82 M undefined
2029e2.42 B undefined699.97 M undefined591.39 M undefined
2028e2.08 B undefined614.38 M undefined490.69 M undefined
2027e2.18 B undefined541.09 M undefined421.77 M undefined
2026e2.08 B undefined712.08 M undefined551.99 M undefined
2025e1.83 B undefined420.83 M undefined333.75 M undefined
20241.54 B undefined454.6 M undefined329.9 M undefined
20231.19 B undefined237.7 M undefined216.8 M undefined
20221.34 B undefined438.8 M undefined349.5 M undefined
20211.04 B undefined240.3 M undefined193.8 M undefined
20201.08 B undefined279.8 M undefined219.9 M undefined
20191.05 B undefined253.9 M undefined200.4 M undefined
2018977.5 M undefined253.1 M undefined330.3 M undefined
20171.03 B undefined285.2 M undefined226 M undefined
20161.07 B undefined292.9 M undefined249 M undefined
20151.02 B undefined269.3 M undefined208.2 M undefined
20141.02 B undefined271.9 M undefined211.3 M undefined
20131.01 B undefined264.9 M undefined206.2 M undefined
2012980.4 M undefined280.8 M undefined208.9 M undefined
2011917.9 M undefined282.6 M undefined209.5 M undefined
2010849.9 M undefined250 M undefined184.7 M undefined
2009771.5 M undefined206.7 M undefined151.4 M undefined
2008710.7 M undefined184.5 M undefined136.3 M undefined
2007683.6 M undefined194.1 M undefined145.5 M undefined
2006641.1 M undefined196.8 M undefined145.1 M undefined
2005585.6 M undefined149.5 M undefined113.9 M undefined

Orion Oyj Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
0.550.590.640.680.710.770.850.920.981.011.021.021.071.030.981.051.081.041.341.191.541.832.082.182.082.422.6
-5.799.576.553.958.5910.128.016.872.650.89-5.71-3.73-5.427.572.57-3.4328.72-11.2729.6918.7413.544.62-4.3716.157.78
68.5470.0967.8667.9467.6165.6366.6766.7464.2960.9360.3960.0060.6759.6360.2960.2360.3956.9663.2855.2661.3551.6745.5043.4945.4839.1636.33
379410435464480506566612630613613609651616589633651593848657946000000
73113145145136151184209208206211208249226330200219193349216329333551421490591649
-54.7928.32--6.2111.0321.8513.59-0.48-0.962.43-1.4219.71-9.2446.02-39.399.50-11.8780.83-38.1152.311.2265.47-23.5916.3920.619.81
---------------------------
---------------------------
141.3141.3140.6141.3141141140.9140.8140.9141140.7140.81140.67140.57140.68140.57140.51140.55140.59140.36140.48000000
---------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Orion Oyj Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Orion Oyj is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (B)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (B)
200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                         
68.4124.511090.4176.1170.5167.2123145.2214.7258.5245.2231.9164.1283.7149294.4216.7332.6106.7205.6
71.978.77582.983.1102.7118.4155.3151.5169.9174192.1200.1199188.8196.5163.4185.8205.7296.8356.9
5.63.514.45.322.35.887.99.226.6251211.414.811.81216.512.8168.820.1
90.699.4107.2121.2131.6122.7131151.3179.2195.5178.7205.7227.5225.4222.1230.3258.1265.2315.6362.2418.6
12.911.509.1015.511.92325.623.116.219.120.517.521.812.311.39.88.850.815.2
0.250.320.310.310.410.420.440.460.510.630.650.670.690.620.730.60.740.690.880.831.02
204196.4187.1186.5192.4192.1187190.6205.4247.3269.1276.4289.1323.1316.9320.9319.6332.6373.3400.9417.6
1.11.11.1111.12.32.51.92.27.79.50.50.40.40.30.30.30.30.30.3
0000000001.21.64.13.91.90.90.70.40.21.10.90.8
34.124.521.923.140.467.169.571.362.357.350.444.240.439.350.237.629.555.5103.8112.987.9
13.513.513.513.513.513.513.513.513.513.513.513.513.513.513.513.513.513.587.287.287.2
49.35257.956.535.136.13740.743.127.76.825.624.156.536.662.68.621.659.211.118.9
302287.5281.5280.6282.4309.9309.3318.6326.2349.2349.1373.3371.5434.7418.5435.6371.9423.7624.9613.3612.7
0.550.610.590.590.70.730.750.780.840.9811.051.061.061.151.041.121.111.51.441.63
                                         
0092.292.292.292.292.292.292.292.292.292.292.292.292.292.292.292.292.292.292.2
0017.817.817.817.817.800000000000000
00333.4337.3308.4329357.3407.7419435.1476.8505.8553.2561.5678.1688.2697.4682.2824.4814.6923.5
296.4396.80000.10.100.1-13.4-54.1-3.1-4.1262.823.5-36.8-8.326.411.314.1
000000000000000000000
0.30.40.440.450.420.440.470.50.510.510.510.590.640.680.770.80.750.770.940.921.03
54.977.129.234.330.242.34966.359.36066.699.1106.183.274.97986.789.6114.4102.387.1
0000000061.367.776.186.182.474.368.483.792.174106.181.8100.4
59.365.150.852.956.469.773.180.92445.347.538.239.921.119.621.532.241.837.751.755.9
0000000028.4000000000000
34.52.22.32.936.422.822.722.70.924.524.59.92.31.1150.93.33.13.817.22930
148.7144.482.390.1123134.8144.8169.9173.9197.5214.7233.3230.7179.7313.8187.5214.1209.2275.4264.8273.4
40.58.37.51.2109.9108.787.566107.4233.3210177.9150.2150.30.66.7105.5104.7196.8171297.2
59.951.351.547.6424344.842.243.132.130.137.837.142.337.841.229.33442.231.835.8
5.94.33.43.32.21.51.31.11.22.231.83.53.53.521.420.935.418.281.180.917.7
106.363.962.452.1154.1153.2133.6109.3151.7267.6271.9219.2190.8196.159.868.8170.2156.9320.1283.7350.7
255208.3144.7142.2277.1288278.4279.2325.6465.1486.6452.5421.5375.8373.6256.3384.3366.1595.5548.5624.1
0.550.610.590.590.70.730.750.780.840.9811.051.061.061.151.061.141.131.541.471.65
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Orion Oyj provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Orion Oyj's financial health and stability.

Assets

Orion Oyj's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Orion Oyj must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Orion Oyj after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Orion Oyj's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
00196194185207254282280267272266314293387252278242440271
0003131343842403737404041415656454751
00000000000000000000
140133-71-68-69-40-78-123-98-94-23-65-92-113-68-38-37-76-119-189
0016-2-23-5-3-151013-137-12901466-15
0032795666910116575257
00525554504979687060475570544962399541
140133141154144204209198221215296254249228230270299215434119
00-22-34-53-60-35-45-49-73-56-43-47-76-66-36-40-85-73-116
-13-13-10-25-51-59-30-43-47-71-54-42-21-7495-34-39-80-154-108
-13-1311921412211261162214-818
00000000000000000000
00-48-7141-17-22-2247119-24-47-37-2-1-15296-369-18
00210-40-400-900-1600-700-170
-154-63-144-148-4-152-182-199-152-73-200-230-237-220-205-371-115-214-159-243
-154.00-63.00------------------
00-118-141-141-134-155-177-199-183-176-183-183-218-203-211-211-211-211-224
-2756-14-1985-5-3-44226943-13-13-67119-134145-77115-226
140.3133.8118.6120.190.6143.9173.6153.4171.9141.9240.3211.7201.4151.9164.1234.6258.4130.7361.32.2
00000000000000000000

Orion Oyj stock margins

The Orion Oyj margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Orion Oyj. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Orion Oyj.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Orion Oyj's sales revenue. A higher gross margin percentage indicates that the Orion Oyj retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Orion Oyj's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Orion Oyj's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Orion Oyj's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Orion Oyj. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Orion Oyj's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Orion Oyj Margin History

Orion Oyj Gross marginOrion Oyj Profit marginOrion Oyj EBIT marginOrion Oyj Profit margin
2030e61.36 %0 %24.95 %
2029e61.36 %28.97 %24.48 %
2028e61.36 %29.54 %23.59 %
2027e61.36 %24.88 %19.39 %
2026e61.36 %34.25 %26.55 %
2025e61.36 %22.98 %18.23 %
202461.36 %29.47 %21.39 %
202355.29 %19.98 %18.22 %
202263.32 %32.73 %26.07 %
202157.01 %23.08 %18.62 %
202060.39 %25.95 %20.4 %
201960.27 %24.16 %19.07 %
201860.32 %25.89 %33.79 %
201759.62 %27.59 %21.87 %
201660.72 %27.28 %23.2 %
201560.04 %26.52 %20.5 %
201460.44 %26.78 %20.81 %
201360.92 %26.31 %20.48 %
201264.3 %28.64 %21.31 %
201166.76 %30.79 %22.82 %
201066.68 %29.42 %21.73 %
200965.63 %26.79 %19.62 %
200867.64 %25.96 %19.18 %
200767.99 %28.39 %21.28 %
200667.99 %30.7 %22.63 %
200570.17 %25.53 %19.45 %

Orion Oyj Stock Sales Revenue, EBIT, Earnings per Share

The Orion Oyj earnings per share therefore indicates how much revenue Orion Oyj has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Orion Oyj earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Orion Oyj's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Orion Oyj’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Orion Oyj's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Orion Oyj Revenue, EBIT and net profit per share

DateOrion Oyj Sales per ShareOrion Oyj EBIT per shareOrion Oyj Earnings per Share
2030e18.54 undefined0 undefined4.63 undefined
2029e17.2 undefined0 undefined4.21 undefined
2028e14.81 undefined0 undefined3.49 undefined
2027e15.48 undefined0 undefined3 undefined
2026e14.8 undefined0 undefined3.93 undefined
2025e13.03 undefined0 undefined2.38 undefined
202410.98 undefined3.24 undefined2.35 undefined
20238.48 undefined1.69 undefined1.54 undefined
20229.54 undefined3.12 undefined2.49 undefined
20217.41 undefined1.71 undefined1.38 undefined
20207.67 undefined1.99 undefined1.57 undefined
20197.48 undefined1.81 undefined1.43 undefined
20186.95 undefined1.8 undefined2.35 undefined
20177.35 undefined2.03 undefined1.61 undefined
20167.63 undefined2.08 undefined1.77 undefined
20157.21 undefined1.91 undefined1.48 undefined
20147.22 undefined1.93 undefined1.5 undefined
20137.14 undefined1.88 undefined1.46 undefined
20126.96 undefined1.99 undefined1.48 undefined
20116.52 undefined2.01 undefined1.49 undefined
20106.03 undefined1.77 undefined1.31 undefined
20095.47 undefined1.47 undefined1.07 undefined
20085.04 undefined1.31 undefined0.97 undefined
20074.84 undefined1.37 undefined1.03 undefined
20064.56 undefined1.4 undefined1.03 undefined
20054.14 undefined1.06 undefined0.81 undefined

Orion Oyj business model

Orion Oyj is a Finnish company that was founded in 1917 as a pharmacy in Turku. Today, Orion Oyj is a leading manufacturer of diagnostic tests, medicines, and other health products. Business model: Orion Oyj focuses on four core areas: Pharmaceutical, Diagnostics, Animal Health, and Fermion. The Pharmaceutical segment is the largest market and includes the production and sale of prescription drugs in the therapy areas of central nervous system disorders, oncology, respiratory diseases, and urology. Orion also produces generics of prescription drugs. The Diagnostics segment includes the development and production of in vitro diagnostic tests (IVDs) for clinical laboratories and point-of-care facilities. Animal Health manufactures products for animal health. Fermion produces active ingredients and intermediates for use in Orion's own and other pharmaceutical companies. Products: Orion offers a wide range of health products. The key products in the pharmaceutical segment are levodopa-based Parkinson's drugs (Stalevo, Comtess, and Opicapone) and drugs for the treatment of asthma and chronic obstructive pulmonary diseases (Easyhaler product family). ORIAHNN (Eligolix and estradiol capsules) was approved by the FDA as the first oral medication for the treatment of uterine fibroids in premenopausal women. In animal health, Orion Oyj offers products focused on the treatment of pet skin diseases, eye and ear infections, and parasite infestations. Orion also has a wide range of IVD products. The focus is on infection diagnostics, offering a wide range of medical tests to detect infections such as hepatitis B, hepatitis C, HIV, tuberculosis, human papillomavirus, and other sexually transmitted diseases. In the diagnostics segment, Orion also produces devices used in blood tests and other tests in hospitals and clinical laboratories. Future prospects: Orion Oyj is expected to invest more in the IVD segment in the coming years. The company sees significant growth potential here and plans to launch new products and test kits on the market. In addition, Orion also invests in spin-off companies focusing on the research and development of promising new technologies and therapies. Orion Oyj has been a leading player in the healthcare market for years. With a wide range of products and a strong focus on research and development, the company has built a solid foundation for future success. Orion Oyj is one of the most popular companies on Eulerpool.com.

Orion Oyj SWOT Analysis

Strengths

Orion Oyj has several strengths that contribute to its market position and success. Firstly, the company has a strong brand reputation and a long history in the pharmaceutical industry. This enhances customer trust and loyalty. Additionally, Orion Oyj has a diverse product portfolio, offering a wide range of pharmaceuticals and specialty drugs, which allows the company to cater to various market segments. Furthermore, the company has a robust research and development (R&D) department, enabling innovation and the development of new and improved drugs. This helps Orion Oyj maintain a competitive edge in the market.

Weaknesses

Despite its strengths, Orion Oyj also has weaknesses that may impact its performance. One weakness is its geographical concentration. The company's operations are primarily focused in Europe, with limited presence in other regions. This reliance on a single market exposes Orion Oyj to risks associated with regional economic downturns or changes in regulations. Moreover, the company's heavy reliance on a few key products leaves it vulnerable to market fluctuations and patent expirations. The lack of diversification in its product offerings poses a potential weakness for Orion Oyj.

Opportunities

Several opportunities exist for Orion Oyj to capitalize on. One important opportunity is the growing demand for specialty and personalized medicine. By investing in the development of drugs tailored to specific patient needs, Orion Oyj can tap into this emerging market and gain a competitive advantage. Additionally, the increasing global aging population presents an opportunity for the company to expand its offerings in geriatric care and related pharmaceuticals. Furthermore, strategic partnerships and collaborations with other pharmaceutical companies can help Orion Oyj access new markets and enhance its distribution network.

Threats

Orion Oyj faces various threats that could impact its operations. Firstly, intense competition within the pharmaceutical industry poses a significant threat. Other major players may introduce competing products, leading to market share erosion. Moreover, regulatory changes and stricter drug approval processes can create obstacles and delays in product development and commercialization. The ongoing globalization of the pharmaceutical industry also exposes Orion Oyj to geopolitical risks, trade barriers, and currency fluctuations. Lastly, the emergence of generic drugs, along with patent expirations, poses a threat to the company's market share and profitability.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Orion Oyj Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Orion Oyj historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Orion Oyj shares outstanding

The number of shares was Orion Oyj in 2024 — This indicates how many shares 140.476 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Orion Oyj earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Orion Oyj's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Orion Oyj’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Orion Oyj's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Orion Oyj dividend history and estimates

In 2024, Orion Oyj paid a dividend amounting to 1.62 EUR. Dividend means that Orion Oyj distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Orion Oyj provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Orion Oyj’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Orion Oyj's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Orion Oyj Dividend History

DateOrion Oyj Dividend
2030e1.73 undefined
2029e1.73 undefined
2028e1.73 undefined
2027e1.73 undefined
2026e1.72 undefined
2025e1.76 undefined
20241.62 undefined
20231.6 undefined
20221.5 undefined
20211.5 undefined
20201.5 undefined
20191.5 undefined
20181.45 undefined
20171.35 undefined
20161.3 undefined
20151.3 undefined
20141.25 undefined
20131.3 undefined
20120.12 undefined
20110.06 undefined
20100.1 undefined
20090.95 undefined
20081 undefined
20071 undefined

Orion Oyj dividend payout ratio

In 2024, Orion Oyj had a payout ratio of 85.81%. The payout ratio indicates the percentage of the company's profits that Orion Oyj distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Orion Oyj represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Orion Oyj could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Orion Oyj's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Orion Oyj Payout Ratio History

DateOrion Oyj Payout ratio
2030e82.38 %
2029e82.81 %
2028e81.65 %
2027e82.69 %
2026e84.1 %
2025e78.16 %
202485.81 %
202388.32 %
202260.34 %
2021108.78 %
202095.84 %
2019105.22 %
201861.97 %
201784.38 %
201673.44 %
201587.92 %
201483.33 %
201389.04 %
20128.11 %
20114.03 %
20107.63 %
200988.79 %
2008103.09 %
200797.09 %
200688.32 %
200588.32 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Orion Oyj.

Orion Oyj latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20250.54 0.59  (9.73 %)2025 Q2
3/31/20250.4 0.44  (8.96 %)2025 Q1
12/31/20240.48 0.52  (8.18 %)2024 Q4
9/30/20241.1 1.14  (3.44 %)2024 Q3
6/30/20240.34 0.37  (8.86 %)2024 Q2
3/31/20240.31 0.31  (-0.51 %)2024 Q1
12/31/20230.46 0.54  (18.47 %)2023 Q4
9/30/20230.34 0.44  (27.91 %)2023 Q3
6/30/20230.36 0.26  (-27.05 %)2023 Q2
3/31/20230.32 0.31  (-2.91 %)2023 Q1
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Orion Oyj stock

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

88

👫 Social

99

🏛️ Governance

68

Environment

Scope 1 - Direct Emissions
5,511
Scope 2 - Indirect emissions from purchased energy
11,726
Scope 3 - Indirect emissions within the value chain
417,464
Total CO₂ emissions
17,237
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees57.1
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Orion Oyj shareholders

%
Name
Stocks
Change
Date
5.09740 % BlackRock Institutional Trust Company, N.A.7,160,62983,3792/17/2025
4.11694 % Ilmarinen Mutual Pension Insurance Company5,783,3142,278,78412/31/2024
3.33689 % Keskinäinen eläkevakuutusyhtiö Varma4,687,52360,0002/29/2024
2.36582 % The Vanguard Group, Inc.3,323,4057,9131/31/2025
1.83441 % Norges Bank Investment Management (NBIM)2,576,904-60,50012/31/2024
1.32763 % Elo Mutual Pension Insurance Company1,865,00022,0002/29/2024
1.10100 % Dimensional Fund Advisors, L.P.1,546,6448,13212/31/2024
0.92542 % Valtion Eläkerahasto1,300,00002/29/2024
0.86731 % Kansaneläkelaitos1,218,36802/29/2024
0.84448 % Amundi Asset Management, SAS1,186,2967,9861/31/2025
1
2
3
4
5
...
10

Orion Oyj Executives and Management Board

Dr. Liisa Hurme

(57)
Orion Oyj President, Chief Executive Officer, Member of the Executive Management Board
Compensation 820,056

Prof. Hilpi Rautelin

(63)
Orion Oyj Independent Vice Chairman of the Board
Compensation 81,100

Mr. Ari Lehtoranta

(62)
Orion Oyj Independent Director
Compensation 72,400

Ms. Karen Sorensen

(63)
Orion Oyj Independent Director
Compensation 66,800

Mr. Veli - Matti Mattila

(63)
Orion Oyj Independent Chairman for the Board
Compensation 61,400
1
2
3
4

Most common questions regarding Orion Oyj

What values and corporate philosophy does Orion Oyj represent?

Orion Oyj represents a strong set of values and corporate philosophy. As a leading pharmaceutical company based in Finland, Orion Oyj is committed to improving people's well-being through the development and commercialization of innovative medicines and treatments. The company's core values include professionalism, reliability, and integrity. Orion Oyj aims to provide effective and safe healthcare solutions while maintaining a high ethical standard in all its operations. With a focus on research and development, Orion Oyj strives to contribute to medical advancements and enhance patient care worldwide. As a result, Orion Oyj maintains a strong reputation as a trustworthy and responsible pharmaceutical company.

In which countries and regions is Orion Oyj primarily present?

Orion Oyj is primarily present in Finland, where it is headquartered. As a Finnish pharmaceutical company, Orion Oyj operates mainly in the Nordic countries, including Sweden, Norway, Denmark, and Iceland. However, the company's reach extends beyond the Nordic region, with a presence in several other countries and regions worldwide. This includes markets in Europe, such as the United Kingdom, Germany, France, and Spain. Orion Oyj also has a global presence with its products being exported to numerous countries in Asia, Africa, the Americas, and Australia.

What significant milestones has the company Orion Oyj achieved?

Orion Oyj has achieved significant milestones throughout its history. The Finnish pharmaceutical company has successfully developed and launched various innovative drugs, contributing to advancements in healthcare. Notably, Orion Oyj achieved a major milestone with the development and commercialization of Stalevo, a medication for the treatment of Parkinson's disease. The company also made significant progress in the field of oncology with the launch of Simdax, a drug used to improve cardiac function in patients with acute decompensated heart failure. Additionally, Orion Oyj has expanded its global presence through strategic collaborations and acquisitions, further solidifying its position as a leading player in the pharmaceutical industry.

What is the history and background of the company Orion Oyj?

Orion Oyj is a renowned Finnish pharmaceutical company. Founded in 1917, Orion has a rich history of over a century in the industry. The company focuses on developing innovative pharmaceuticals and diagnostic tests, ensuring the well-being of individuals globally. Throughout its existence, Orion Oyj has grown to become one of the leading pharmaceutical companies in Northern Europe, with a strong emphasis on research and development. With a diverse product portfolio that includes prescription medicines, generic drugs, and active pharmaceutical ingredients, Orion Oyj aims to improve people's lives and provide effective healthcare solutions.

Who are the main competitors of Orion Oyj in the market?

The main competitors of Orion Oyj in the market include Novartis AG, Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc.

In which industries is Orion Oyj primarily active?

Orion Oyj is primarily active in the pharmaceutical industry. As a leading Finnish pharmaceutical company, Orion Oyj specializes in the development, manufacturing, and marketing of innovative pharmaceuticals and active pharmaceutical ingredients. With a strategic focus on neurological and respiratory diseases, Orion Oyj aims to improve people's well-being and contribute to medical advancements. Not only does Orion Oyj offer a diverse range of products in these therapeutic areas, but it also operates globally, exporting its pharmaceuticals to numerous countries. This commitment to the pharmaceutical industry makes Orion Oyj a key player in the healthcare sector.

What is the business model of Orion Oyj?

The business model of Orion Oyj revolves around the development, manufacturing, and marketing of pharmaceuticals and diagnostic tests. Orion Oyj specializes in various therapeutic areas including neurological disorders, respiratory diseases, and oncology. They focus on research and development of new innovative drugs to address unmet medical needs. By combining expertise in pharmaceuticals and diagnostics, Orion Oyj aims to provide effective and safe treatment options for patients globally. With its strong commitment to scientific excellence and continuous innovation, Orion Oyj strives to improve the quality of life for individuals affected by various diseases.

What is the P/E ratio of Orion Oyj 2025?

The P/E ratio cannot be calculated for Orion Oyj at the moment.

What is the P/S ratio of Orion Oyj 2025?

The P/S cannot be calculated for Orion Oyj currently.

What is the Quality Investing of Orion Oyj?

The Quality Investing for Orion Oyj is 9/10.

What is the revenue of Orion Oyj 2025?

The expected Orion Oyj revenue is 1.83 B EUR.

How high is the profit of Orion Oyj 2025?

The expected Orion Oyj profit is 333.75 M EUR.

What is the business model of Orion Oyj

Orion Oyj is a Finnish company that was founded in 1917 and is now considered a leading manufacturer of pharmaceuticals, diagnostics, and animal health products in Northern and Central Europe. The company is divided into three divisions: human pharmaceuticals, specialty pharmaceuticals, and animal health. The human pharmaceuticals division is the main source of revenue for the company and offers a wide range of prescription drugs for various therapy areas such as neurology, oncology, urology, gastroenterology, and cardiology. Orion Oyj continuously develops innovative products and technologies for the healthcare industry and has had numerous successful product launches in recent years. The specialty pharmaceuticals division specializes in manufacturing medications for rare diseases. Among other products, the company manufactures treatments for Huntington's disease, ALS (Amyotrophic Lateral Sclerosis), and Parkinson's disease. The third business area is animal health. Orion Oyj offers a wide range of medications for livestock and pets. The company is a leader in the production of free-range pig vaccines, which are in high demand, particularly in Northern Europe and the Baltic states. Orion Oyj is headquartered in Espoo, Finland, and employs over 3,000 people worldwide. The company is also listed on the Finnish stock exchange and had a revenue of approximately 1.1 billion euros in 2019. Orion Oyj has a clear strategy regarding its products and services. It focuses on strong partnerships and investments in research and development as well as production. The company aims to strengthen its position as a market leader in Northern Europe and the specialized pharmaceutical industry worldwide. Additionally, Orion Oyj has a strong local presence in many European countries and operates production facilities in Finland and Germany. The high standards of product quality and production safety are supported by Orion Oyj's quality management system. As part of its international expansion, the company has also expanded into other markets, such as South America. In doing so, the company prioritizes sustainability and ethics. It aims to promote best practices in ecological, social, and community matters both within and outside the company. Overall, Orion Oyj is a company that offers a wide range of products and services in the field of human pharmaceuticals, specialty pharmaceuticals, and animal health. With its strong partnerships, investments in research and development, and a clear focus on the highest product quality and production safety, the company is well-equipped to expand its position as a leading provider in Northern Europe and the specialized pharmaceutical industry worldwide.

What is the Orion Oyj dividend?

Orion Oyj pays a dividend of 1.5 EUR distributed over payouts per year.

How often does Orion Oyj pay dividends?

The dividend cannot currently be calculated for Orion Oyj or the company does not pay out a dividend.

What is the Orion Oyj ISIN?

The ISIN of Orion Oyj is FI0009014377.

What is the Orion Oyj WKN?

The WKN of Orion Oyj is A0J3QM.

What is the Orion Oyj ticker?

The ticker of Orion Oyj is ORNBV.HE.

How much dividend does Orion Oyj pay?

Over the past 12 months, Orion Oyj paid a dividend of 1.62 EUR . This corresponds to a dividend yield of about . For the coming 12 months, Orion Oyj is expected to pay a dividend of 1.72 EUR.

What is the dividend yield of Orion Oyj?

The current dividend yield of Orion Oyj is .

When does Orion Oyj pay dividends?

Orion Oyj pays a quarterly dividend. This is distributed in the months of April, November, May, November.

How secure is the dividend of Orion Oyj?

Orion Oyj paid dividends every year for the past 24 years.

What is the dividend of Orion Oyj?

For the upcoming 12 months, dividends amounting to 1.72 EUR are expected. This corresponds to a dividend yield of 2.45 %.

In which sector is Orion Oyj located?

Orion Oyj is assigned to the 'Health' sector.

Wann musste ich die Aktien von Orion Oyj kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Orion Oyj from 10/23/2025 amounting to 0.82 EUR, you needed to have the stock in your portfolio before the ex-date on 10/15/2025.

When did Orion Oyj pay the last dividend?

The last dividend was paid out on 10/23/2025.

What was the dividend of Orion Oyj in the year 2024?

In the year 2024, Orion Oyj distributed 1.6 EUR as dividends.

In which currency does Orion Oyj pay out the dividend?

The dividends of Orion Oyj are distributed in EUR.

All fundamentals about Orion Oyj

Our stock analysis for Orion Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.